Johnson & Johnson (JNJ) Minority Interest (2010 - 2023)
Johnson & Johnson's (JNJ) quarterly Minority Interest came in at $1.3 billion in Q3 2023, up 113.56% quarter-over-quarter from $590.0 million in Q1 2010.
Johnson & Johnson (JNJ) Minority Interest (2010 - 2023) Analysis & Trends
Johnson & Johnson has disclosed Minority Interest across 2 years of filings, most recently posting $1.3 billion for Q3 2023.
- Minority Interest for Q3 2023 came in at $1.3 billion, changed N/A year-over-year; the trailing twelve-month figure through Jul 2023 was $1.3 billion (changed N/A YoY), and the FY2010 annual result was $590.0 million, changed N/A from the prior year.
- Minority Interest came in at $1.3 billion for Q3 2023 at Johnson & Johnson, up from $590.0 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $1.3 billion in Q3 2023 to a low of $1.3 billion in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn |
| 10 | Novartis Ag | 112.59 Bn | 111.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 2, 2023 | 1.26 Bn |
| Jan 3, 2010 | 590.00 Mn |